Article Versions Notes

James JR, Curd J, Ashworth JC, Abuhantash M, Grundy M, Seedhouse CH, Arkill KP, Wright AJ, Merry CLR, Thompson A. Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML. International Journal of Molecular Sciences. 2023; 24(4):4235. https://doi.org/10.3390/ijms24044235

James, Jenna R., Johnathan Curd, Jennifer C. Ashworth, Mays Abuhantash, Martin Grundy, Claire H. Seedhouse, Kenton P. Arkill, Amanda J. Wright, Catherine L. R. Merry, and Alexander Thompson. 2023. "Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML" International Journal of Molecular Sciences 24, no. 4: 4235. https://doi.org/10.3390/ijms24044235

James, J. R., Curd, J., Ashworth, J. C., Abuhantash, M., Grundy, M., Seedhouse, C. H., Arkill, K. P., Wright, A. J., Merry, C. L. R., & Thompson, A. (2023). Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML. International Journal of Molecular Sciences, 24(4), 4235. https://doi.org/10.3390/ijms24044235